Table 1.
Parameter | n, % |
---|---|
Age (n = 81) | |
Range | 12–82 |
Median | 64 |
Mean ± SD | 58 ± 17.4 |
Sex (n = 81) | |
Female | 34, 42% |
Male | 47, 58% |
Localization (n = 81) | |
Skull | 30, 37% |
Sacrum | 27, 33.3% |
Mobile spine | 24, 29.7% |
Recurrence (n = 81) | |
Yes | 52, 64.2% |
No | 29, 35.8% |
Multiple recurrences (n = 80) | |
Yes | 24, 30% |
No | 56, 70% |
Tumor size (in mm **) | |
Range | 19–144 |
Median | 43 |
Mean ± SD | 50.6 ± 27.5 |
Principal treatment at diagnosis (n = 85) | |
Surgical | 72, 84.7% |
Radiotherapy | 10, 11.8% |
Palliative | 3, 3.5% |
Adjuvant therapy (n = 40) | |
Radiotherapy | 36, 90% |
Surgical | 3, 7.5% |
immunotherapy | 1, 2.5% |
Follow-up (n = 81) | |
Range | 2–264 |
Median | 60 |
Mean ± SD | 69.5 ± 59.5 |
Patient status (n = 81) | |
Alive | 66, 81.5% |
Dead * | 15, 18.5% |
Overall survival (n = 81) | |
Range | 2–264 |
Median (log-rank) | Not reached |
* = only disease-associated deaths. n denotes the number of cases with available data. ** = size was available for only 38 cases, while tumor volume was not available.